UNSW medical researchers say more Australians with type 2 diabetes need to be offered add-on medications that would better protect them from heart and kidney disease—which are among the major causes of death for people ...
Sep 12, 2024
0
4
Common medicines used to treat conditions including heartburn, reflux, indigestion and stomach ulcers may be the subject of a class action lawsuit in Australia.
Sep 12, 2024
0
2
Researchers at the Experimental and Clinical Research Center of Max Delbrück Center and Charité—Universitätsmedizin Berlin (ECRC) have found that different anatomical sections of the gastrointestinal tracts of mice carry ...
Sep 12, 2024
0
0
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don't have diabetes, whether ...
Sep 11, 2024
0
0
Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5% of the population, or 10.5 million U.S. adults, according ...
Sep 11, 2024
0
109
A new collaborative project has highlighted the importance of accessible and culturally safe health care for First Nations people.
Sep 11, 2024
0
0
Polycystic kidney disease (PKD) is an intractable disorder that causes fluid-filled cysts to grow in the kidneys. It is typically seen in adults. As one of the most prevalent hereditary kidney diseases, the autosomal dominant ...
Sep 10, 2024
0
0
Recreational drug use is associated with a tripled risk for a repeat serious cardiovascular event within one year of hospitalization, according to a study presented at the European Society of Cardiology Congress 2024, held ...
Sep 7, 2024
0
0
A study published in Nature Communications provides new insight into how damaged cells interact within disease-promoting microenvironments following acute kidney injury, or AKI. With limited treatment options, AKI frequently ...
Sep 5, 2024
0
22
The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), a Mount Sinai-led global ...
Sep 2, 2024
0
0
